Get the Stockscreener App
1.55
1.90%
-0.03
After Hours:
1.53
-0.02
-1.29%
Theratechnologies Inc Stock (THTX) Latest News
Theratechnologies Inc. - Baystreet.ca
Stocks In Play: Theratechnologies Inc. - Barchart
Theratechnologies CROI Presentation Highlights Limitations - GlobeNewswire
Theratechnologies Reports Encouraging Results From PROMISE-US Trial Of Ibalizumab - Nasdaq
Theratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of ... - The Bakersfield Californian
Theratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of Ibalizumab at CROI - GlobeNewswire
Groundbreaking Research Shows BMI Misses Critical Heart Risks in 43% of HIV Patients - StockTitan
Theratechnologies Presents Encouraging Virologic - GlobeNewswire
Theratechnologies Inc. to Host Earnings Call - ACCESS Newswire
Theratechnologies, Inc. to Host Earnings Call - ACCESS Newswire
Research Analysts Issue Forecasts for THTX FY2027 Earnings - Defense World
FY2025 EPS Estimates for TSE:TH Reduced by Leede Financial - MarketBeat
Theratechnologies (NASDAQ:THTX) Posts Quarterly Earnings Results, Misses Expectations By $0.14 EPS - MarketBeat
Leede Financial Brokers Reduce Earnings Estimates for TSE:TH - Defense World
Theratechnologies (NASDAQ:THTX) Issues Earnings Results - MarketBeat
Theratechnologies Inc. (NASDAQ:THTX) Short Interest Update - MarketBeat
Theratechnologies Inc. (NASDAQ:THTX) Short Interest Up 212.7% in February - Defense World
Research Analysts Set Expectations for THTX FY2025 Earnings - Defense World
Theratechnologies’ Earnings Call: Growth Amid Challenges - TipRanks
What is Leede Financial's Estimate for THTX FY2025 Earnings? - MarketBeat
Theratechnologies Inc (THTX) Q4 2024 Earnings Call Highlights: S - GuruFocus.com
Theratechnologies Inc (THTX) Q4 2024 Earnings Call Highlights: Strong EBITDA Turnaround and ... - Yahoo Finance
Theratechnologies Reports Strong Fiscal 2024 Performance - TipRanks
Theratechnologies reports Q4 revenue $25M vs $23.45M last year - TipRanks
Theratechnologies: Fiscal Q4 Earnings Snapshot - mySA
Theratechnologies Inc reports results for the quarter ended November 30Earnings Summary - TradingView
Earnings call transcript: Theratechnologies Q4 2024 sees growth amid strategic shifts - Investing.com UK
Theratechnologies: Fiscal Q4 Earnings Snapshot -February 26, 2025 at 07:55 am EST - Marketscreener.com
Theratechnologies Achieves Record Financial Results and Secures Future Growth - TipRanks
Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2024 - GlobeNewswire
From Losses to Record Profits: How Theratechnologies Turned Around Its Financials in 2024 - StockTitan
Theratechnologies Inc (TSX:TH) Q4 2024: Everything You Need to K - GuruFocus.com
Theratechnologies Inc (TSX:TH) Q4 2024: Everything You Need to Know Ahead of Earnings - Yahoo Finance
Theratechnologies Resumes EGRIFTA SV® Distribution Following FDA Approval - TipRanks
Theratechnologies (THTX) Stock Price, News & Analysis - MarketBeat
Theratechnologies (THTX) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Short Interest in Theratechnologies Inc. (NASDAQ:THTX) Drops By 73.4% - MarketBeat
Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025 - ADVFN
Theratechnologies (THTX) to Release Quarterly Earnings on Wednesday - MarketBeat
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update - The Manila Times
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide ... - Walla Walla Union-Bulletin
Q4 Earnings Preview: Theratechnologies CEO to Unveil Strategic Vision Alongside 2024 Financial Results - StockTitan
Theratechnologies Resumes EGRIFTA SV® Distribution Following FDA Clearance - TipRanks
Major HIV Treatment Back in Stock: FDA Greenlights EGRIFTA SV Distribution to US Pharmacies - StockTitan
Theratechnologies Resumes Distribution of EGRIFTA SV® - GlobeNewswire
Theratechnologies (TSE:TH) Trading Up 1.9%Here's Why - MarketBeat
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):